FAQs
What is the role of a District Business Manager at AstraZeneca?
The District Business Manager plays a pivotal role in channeling scientific capabilities to positively impact patients' lives, focusing on CVRM diseases, leading sales teams, driving strategic execution of brand plans, and managing resources effectively.
What qualifications are essential for this role?
Essential qualifications include a Bachelor’s Degree, sales and/or sales leadership experience, proven ability to manage and lead large teams, and a comprehensive understanding of the development and commercialization of pharmaceutical products in the Philippines.
Is an MBA preferred for this position?
Yes, an MBA in a relevant field is considered a desirable qualification for this role.
What kind of experience is valued for this position?
Experience in Consumer and/or Managed Markets roles is considered desirable, along with proven sales management and leadership skills.
What skills should candidates have regarding technology and software?
Proficiency in MS Office applications, particularly PowerPoint, Excel, and Word, is desirable for this position.
Are there opportunities for mentorship in this role?
Yes, the District Business Manager is expected to serve as a mentor for new and junior District Business Managers.
What type of team culture does AstraZeneca promote?
AstraZeneca promotes an inclusive and diverse team culture that values different perspectives and encourages personal growth, lifelong learning, and development.
How does AstraZeneca ensure equality in employment?
AstraZeneca is committed to building an inclusive team representing diverse backgrounds and complies with all applicable laws and regulations on non-discrimination in employment and recruitment.
Will I be involved in regional or national activities in this role?
Yes, the District Business Manager will lead regional and national commercial activities as part of their responsibilities.
What is the impact of this role on patient care?
The District Business Manager will have a direct impact on shaping strategies that address the complexities of CVRM diseases, thereby improving patient outcomes and experiences with AstraZeneca's products.
